Salivary gland tumors

Area of Science:

• Oncology
• Head and Neck Surgery
• Pathology

Background:

• Salivary gland tumors represent a diverse group of neoplasms.
• Understanding the epidemiology and treatment outcomes is crucial for patient management.

Purpose of the Study:

• To analyze the characteristics and outcomes of benign and malignant salivary gland tumors.
• To evaluate the effectiveness of initial treatment in a large patient cohort.

Main Methods:

• Retrospective review of 643 patients diagnosed with salivary gland tumors between 1958 and 1972.
• Data collection included tumor type (benign vs. malignant), patient demographics, and treatment outcomes.
• Malignant tumor patients were assessed in a multidisciplinary head and neck clinic.

Main Results:

• A total of 328 malignant and 375 benign tumors were identified.
• Malignant tumors had a median age of 58 (M:F ratio 1.2:1), while benign tumors had a median age of 46 (M:F ratio 0.8:1).
• Initial treatment controlled the primary tumor in 44% of malignant cases and 80% of benign cases.
• Five and 10-year actuarial survival for malignant tumors was 59.4% and 45.6%, respectively.

Conclusions:

• Benign salivary gland tumors demonstrate higher rates of initial treatment control compared to malignant tumors.
• Survival rates for malignant salivary gland tumors remain a significant challenge, underscoring the need for effective therapeutic strategies.